Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spruce Biosciences, Inc. - Common Stock (NQ:SPRB)

55.81 -10.48 (-15.81%)
Streaming Delayed Price Updated: 10:09 AM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Spruce Biosciences, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Spruce Biosciences to Participate in November Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in June Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in May Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Libbie Mansell, Ph.D., M.B.A., R.A.C., as Chief Regulatory and Quality Officer
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in the Piper Sandler 33rd Annual Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Mike Grey as Interim CEO
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in September Investor Conferences
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day
From Spruce Biosciences
Via Business Wire
News headline image
Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Presents Phase 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia at 23rd European Congress of Endocrinology
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference
From Spruce Biosciences, Inc.
Via Business Wire
News headline image
Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates
From Spruce Biosciences, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.